Surgical sutures are sterile surgical threads used to seal surgical incisions. They aid in the reattachment of human tissues following surgery or trauma. Absorbable and non-absorbable sutures are the two primary types of sutures. They are often manufactured from a range of natural or synthetic materials.

In 2021, the market for surgical sutures was worth USD 4.04 billion, and by 2030 it will be worth USD 6.97 billion, at a 6.23% CAGR during the forecast period. 

The global surgical sutures market has grown due to an increase in surgical procedures performed around the world, an increase in the prevalence of chronic diseases, and a growing desire for minimally invasive techniques. However, the availability of substitute wound care management solutions restrains market expansion. On the other hand, technical development and potential in underdeveloped nations will create profitable prospects for market participants in the future.

Market Dynamics

Drivers

The growing geriatric population, increasing disposable income, new technology availability, and growing procedural safety have all contributed to a surge in cosmetic and aesthetic operations in recent years. Because of the global popularity of these treatments, surgical suture market participants have a significant development opportunity. Per the American Society of Plastic Surgeons, nearly 17.9 million surgical and minimally invasive procedures were carried out in 2017 in the United States, representing a 1% rise in cosmetic surgeries between 2016 and 2017. Similar trends were observed in Europe, with increases of 134% in Italy, 0.5% in France, and 9% in Germany.

Furthermore, the market is significantly driven by an increase in cosmetic procedures as well as technological developments such as hybrid fractional lasers and cryolipolysis. 

Restraints

The availability of alternatives for wound healing, such as surgical staplers, poses a threat to market expansion. Furthermore, adverse effects related to the use of sutures, such as surgical site infection and the expensive cost of antibacterial devices, impede the surgical sutures market.

Opportunity

Many governments in emerging economies are attempting to make health insurance available to a greater number of people in their countries so that they can have access to adequate treatment. These variables boost the likelihood that the suture market will expand globally in such economies.

Market Segmentation 

By Product Type

On the basis of product type, the surgical sutures market is segmented into non-absorbable and absorbable. 

In 2021, the absorbable segment ruled the entire market with a revenue share of nearly 55%. It is due to its capability to provide temporary support to wounds while they heal and its capacity to withstand routine stress. Additionally, absorbable sutures are becoming necessary because they are naturally biodegradable. As a result, market leaders are investing in R&D, which will help the absorbable sector thrive in the future.

Non-absorbable sutures have a smaller market share than absorbable sutures since they cannot decay or disintegrate.

By Application

In terms of application, the market is segmented into orthopaedic surgeries, general surgeries, cardiovascular surgeries, ophthalmic surgeries, gynaecological surgeries, and other surgeries. 

With a revenue share of more than 40%, the other sector ruled the surgical suture market in 2021. Cardiovascular surgery had the second-largest revenue share in 2021. It is due to the high rate of cardiovascular disease and surgeries performed worldwide, the availability of skilled specialists, favorable reimbursement policies, and improvements in diagnostic technology. Due to the significant rise in cardiac surgeries as a result, demand for surgical sutures has increased during the forecast period.

By End-User

On the basis of end-user, the market is segmented into clinics & physician offices, hospitals, and ambulatory surgical centers. 

The hospital segment held the majority of the market, with the largest revenue share of nearly 74.7% in 2020. This is due to the growing number of advanced surgeries performed in hospitals, the growing geriatric population, appealing payment schemes for hospital treatments, and the increasing number of new hospitals, particularly in emerging nations.

Regional Overview

In 2021, North America led the entire regional market with a considerable revenue share of approximately 40%. It is due to the emergence of local and major players, favorable reimbursement scenarios, expanding government initiatives, and enhanced healthcare infrastructure. Additionally, the significant share of North America is also due to technological enhancements and strong domestic wealth.

However, Asia Pacific will grow at a rapid rate during the forecast period. This is attributable to the expanding senior population base, which is more prone to undergo surgery and an increase in government investment in healthcare infrastructure to address the region’s unmet needs. China, India, and Japan are amongst the largest markets in the Asia Pacific area. Another significant driver propelling the market in this area toward exponential growth is the rise of medical tourism in nations like India, Singapore, and Malaysia.

Key Players 

  • Boston Scientific Corporation
  • Medtronic plc
  • Mellon Medical B.V.
  • Teleflex Incorporated
  • Smith & Nephew
  • B. Braun Melsungen AG
  • EndoEvolution, LLC
  • DemeTech Corporation
  • Peters Surgical
  • Ethicon Inc. (Johnson & Johnson)
  • CONMED Corporation
  • InternacionalFarmac√©utica S.A. De C.V.
  • Sutures India
  • Surgical Specialties Corporation

In 2021, the market for surgical sutures was worth USD 4.04 billion, and by 2030 it will be worth USD 6.97 billion, at a 6.23% CAGR during the forecast period. Factors propelling the growth of the surgical sutures market are the rising rate of the geriatric population, technological improvements, and the rising number of surgical procedures.

Related Reports:

Electric Vehicle Charging Station Market Report – The global electric vehicle charging station market will witness a robust CAGR of 31.14%, valued at $12.41 billion in 2021, expected to appreciate and reach $142.36 billion by 2030, confirms Strategic Market Research.

Leave a Reply

Your email address will not be published. Required fields are marked *